Breaking News, Financial News

Kendle 2Q09

Early-stage revenues dropped 15% to $7.3 million in 2Q09, but rose 15% for YTD09

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Kendle Int’l. 2Q Revenues: $107.4 million (-15%) 2Q Earnings: $3.2 million (-48%) YTD Revenues: $215.5 million (-11%) YTD Earnings: $4.1 million (-61%) Comments: New business awards were $132 million, while there were $48 million in contract cancellations, comprising 5% of the company’s backlog. Early-stage revenues dropped 15% to $7.3 million in 2Q09, but rose 15% for YTD09. Late-stage revenues fell 17% to $96.6 million for 2Q09 and 13% in YTD09 to $193.2 million. Dur...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters